Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Recruiting · NCT07428447 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease | central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Not stated | 2026-09-18 | NCT07428447 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CND Life Sciences | 6 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CND Clinical Research Center | Scottsdale | United States | 1 |
| Neurology One | Orlando | United States | 2 |
| Norton Healthcare | Louisville | United States | 14 |
| Veracity Neurosciences LLC | Memphis | United States | 1 |